• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

变构调节 Alpha7 烟碱型乙酰胆碱受体:通过元动力学和本征动力学获得的机制见解。

Allosteric Modulation of Alpha7 Nicotinic Receptors: Mechanistic Insight through Metadynamics and Essential Dynamics.

机构信息

Dipartimento di Scienze Farmaceutiche, Sezione di Chimica Farmaceutica "Pietro Pratesi", Università degli Studi di Milano , Via L. Mangiagalli 25, 20133 Milan, Italy.

Institute of Research in Biomedicine (IRB) , Via Vincenzo Vela 6, 6500 Bellinzona, Switzerland.

出版信息

J Chem Inf Model. 2015 Dec 28;55(12):2528-39. doi: 10.1021/acs.jcim.5b00459. Epub 2015 Nov 20.

DOI:10.1021/acs.jcim.5b00459
PMID:26569022
Abstract

Increasing attention has recently been devoted to allosteric modulators, as they can provide inherent advantages over classic receptor agonists. In the field of nicotinic receptors (nAChRs), the main advantage is that allosteric modulators can trigger pharmacological responses, limiting receptor desensitization. Most of the known allosteric ligands are "positive allosteric modulators" (PAMs), which increase both sensitivity to receptor agonists and current amplitude. Intriguingly, some allosteric modulators are also able to activate the α7 receptor (α7-nAChR) even in the absence of orthosteric agonists. These compounds have been named "ago-allosteric modulators" and GAT107 has been studied in depth because of its unique mechanism of action. We here investigate by molecular dynamics simulations, metadynamics, and essential dynamics the activation mechanism of α7-nAChR, in the presence of different nicotinic modulators. We determine the free energy profiles associated with the closed-to-open motion of the loop C, and we highlight mechanistic differences observed in the presence of different modulators. In particular, we demonstrate that GAT107 triggers conformational motions and cross-talk similar to those observed when the α7-nACh receptor is in complex with both an agonist and an allosteric modulator.

摘要

最近,人们越来越关注变构调节剂,因为它们相对于经典的受体激动剂具有内在优势。在烟碱型乙酰胆碱受体 (nAChR) 领域,主要的优势是变构调节剂可以引发药理学反应,限制受体脱敏。大多数已知的变构配体都是“正变构调节剂”(PAMs),它们既能提高受体激动剂的敏感性,又能提高电流幅度。有趣的是,一些变构调节剂即使没有正变构激动剂也能激活 α7 受体(α7-nAChR)。这些化合物被称为“前变构调节剂”,由于其独特的作用机制,GAT107 已被深入研究。我们在这里通过分子动力学模拟、元动力学和基本动力学研究了不同烟碱类调节剂存在时 α7-nAChR 的激活机制。我们确定了与环 C 闭合到开放运动相关的自由能曲线,并突出了在存在不同调节剂时观察到的机制差异。特别是,我们证明 GAT107 触发的构象运动和串扰与当 α7-nACh 受体与激动剂和变构调节剂复合物时观察到的相似。

相似文献

1
Allosteric Modulation of Alpha7 Nicotinic Receptors: Mechanistic Insight through Metadynamics and Essential Dynamics.变构调节 Alpha7 烟碱型乙酰胆碱受体:通过元动力学和本征动力学获得的机制见解。
J Chem Inf Model. 2015 Dec 28;55(12):2528-39. doi: 10.1021/acs.jcim.5b00459. Epub 2015 Nov 20.
2
Allosteric Agonism of 7 Nicotinic Acetylcholine Receptors: Receptor Modulation Outside the Orthosteric Site.7 型烟碱型乙酰胆碱受体的变构激动作用:变构部位以外的受体调节。
Mol Pharmacol. 2019 Jun;95(6):606-614. doi: 10.1124/mol.119.115758. Epub 2019 Apr 3.
3
Potentiation and allosteric agonist activation of α7 nicotinic acetylcholine receptors: binding sites and hypotheses.α7 型烟碱型乙酰胆碱受体的增效作用和变构激动剂激活:结合位点和假说。
Pharmacol Res. 2023 May;191:106759. doi: 10.1016/j.phrs.2023.106759. Epub 2023 Apr 4.
4
The activity of GAT107, an allosteric activator and positive modulator of α7 nicotinic acetylcholine receptors (nAChR), is regulated by aromatic amino acids that span the subunit interface.GAT107 的活性是由跨越亚基界面的芳香族氨基酸调节的,GAT107 是一种变构激活剂和α7 烟碱型乙酰胆碱受体 (nAChR) 的正变构调节剂。
J Biol Chem. 2014 Feb 14;289(7):4515-31. doi: 10.1074/jbc.M113.524603. Epub 2013 Dec 20.
5
Molecular interactions of type I and type II positive allosteric modulators with the human α7 nicotinic acetylcholine receptor: an in silico study.I 型和 II 型正变构调节剂与人 α7 烟碱型乙酰胆碱受体的分子相互作用:一项计算机研究。
J Biomol Struct Dyn. 2019 Feb;37(2):411-439. doi: 10.1080/07391102.2018.1427634. Epub 2018 Feb 16.
6
Structurally similar allosteric modulators of α7 nicotinic acetylcholine receptors exhibit five distinct pharmacological effects.α7烟碱型乙酰胆碱受体结构相似的变构调节剂具有五种不同的药理作用。
J Biol Chem. 2015 Feb 6;290(6):3552-62. doi: 10.1074/jbc.M114.619221. Epub 2014 Dec 16.
7
Critical Molecular Determinants of α7 Nicotinic Acetylcholine Receptor Allosteric Activation: SEPARATION OF DIRECT ALLOSTERIC ACTIVATION AND POSITIVE ALLOSTERIC MODULATION.α7烟碱型乙酰胆碱受体变构激活的关键分子决定因素:直接变构激活与正变构调节的分离
J Biol Chem. 2016 Mar 4;291(10):5049-67. doi: 10.1074/jbc.M115.692392. Epub 2016 Jan 7.
8
The α7 nicotinic receptor dual allosteric agonist and positive allosteric modulator GAT107 reverses nociception in mouse models of inflammatory and neuropathic pain.α7烟碱型受体双重变构激动剂和正变构调节剂GAT107可逆转炎症性疼痛和神经性疼痛小鼠模型中的伤害感受。
Br J Pharmacol. 2016 Aug;173(16):2506-20. doi: 10.1111/bph.13528. Epub 2016 Jul 18.
9
Molecular modelling studies on ɑ7 nicotinic receptor allosteric modulators yields novel filter-based virtual screening protocol.对α7烟碱型受体变构调节剂的分子模拟研究产生了基于过滤器的新型虚拟筛选方案。
J Mol Graph Model. 2019 Nov;92:44-54. doi: 10.1016/j.jmgm.2019.07.001. Epub 2019 Jul 2.
10
Macroscopic and Microscopic Activation of 7 Nicotinic Acetylcholine Receptors by the Structurally Unrelated Allosteric Agonist-Positive Allosteric Modulators (ago-PAMs) B-973B and GAT107.7 型烟碱型乙酰胆碱受体的宏观和微观激活:结构不相关的变构激动剂-正变构调节剂(ago-PAMs)B-973B 和 GAT107。
Mol Pharmacol. 2019 Jan;95(1):43-61. doi: 10.1124/mol.118.113340. Epub 2018 Oct 22.

引用本文的文献

1
α7nAChR on B cells directs T cell differentiation to prevent viral myocarditis.B细胞上的α7烟碱型乙酰胆碱受体指导T细胞分化以预防病毒性心肌炎。
JCI Insight. 2025 May 8;10(9). doi: 10.1172/jci.insight.189323.
2
Exploring the Binding Mechanism of ADGRG2 Through Metadynamics and Biochemical Analysis.通过元动力学和生化分析探索ADGRG2的结合机制。
Int J Mol Sci. 2024 Dec 28;26(1):167. doi: 10.3390/ijms26010167.
3
The Mechanisms Mediated by α7 Acetylcholine Nicotinic Receptors May Contribute to Peripheral Nerve Regeneration.α7 乙酰胆碱型尼古丁受体介导的机制可能有助于周围神经再生。
Molecules. 2021 Dec 18;26(24):7668. doi: 10.3390/molecules26247668.
4
A potential interaction between the SARS-CoV-2 spike protein and nicotinic acetylcholine receptors.SARS-CoV-2 刺突蛋白与烟碱型乙酰胆碱受体的潜在相互作用。
Biophys J. 2021 Mar 16;120(6):983-993. doi: 10.1016/j.bpj.2021.01.037. Epub 2021 Feb 18.
5
Orthosteric and Allosteric Activation of Human 5-HTA Receptors.人 5-HT1A 受体的变构激活和正构激活。
Biophys J. 2020 Oct 20;119(8):1670-1682. doi: 10.1016/j.bpj.2020.08.029. Epub 2020 Sep 2.
6
Nicotinic receptor pharmacology in silico: Insights and challenges.烟碱型乙酰胆碱受体的计算机药理学:研究进展与挑战。
Neuropharmacology. 2020 Oct 15;177:108257. doi: 10.1016/j.neuropharm.2020.108257. Epub 2020 Jul 29.
7
Exploring Conformational Dynamics of the Extracellular Domain of the GABA Receptor: A Path-Metadynamics Study.探索 GABA 受体细胞外结构域的构象动力学:一种路径元动力学研究。
J Chem Inf Model. 2020 Apr 27;60(4):2294-2303. doi: 10.1021/acs.jcim.0c00163. Epub 2020 Apr 15.
8
In Silico Modeling of the α7 Nicotinic Acetylcholine Receptor: New Pharmacological Challenges Associated with Multiple Modes of Signaling.计算机模拟 α7 烟碱型乙酰胆碱受体:与多种信号转导模式相关的新的药理学挑战。
Mini Rev Med Chem. 2020;20(10):841-864. doi: 10.2174/1389557520666200130105256.
9
An overview of recent molecular dynamics applications as medicinal chemistry tools for the undruggable site challenge.近期分子动力学作为应对不可成药靶点挑战的药物化学工具的应用综述。
Medchemcomm. 2018 Apr 19;9(6):920-936. doi: 10.1039/c8md00166a. eCollection 2018 Jun 1.